Imperial College London

Imperial College London logo
πŸ‡§πŸ‡ͺBelgium
Ownership
Private
Established
1907-07-08
Employees
5K
Market Cap
-
Website
http://www.imperial.ac.uk

Prednisolone Pharmacokinetics in Severe Asthma

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-04-21
Last Posted Date
2019-11-20
Lead Sponsor
Imperial College London
Target Recruit Count
5
Registration Number
NCT00662298
Locations
πŸ‡¬πŸ‡§

Asthma Laboratory, Royal Brompton Hospital, London, United Kingdom

Inhaled Corticosteroids on Airway Smooth Muscle in Asthma

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2008-04-21
Last Posted Date
2019-09-13
Lead Sponsor
Imperial College London
Registration Number
NCT00661973
Locations
πŸ‡¬πŸ‡§

Asthma lab, Royal Brompton Hospital, Sydney Street, London, United Kingdom

A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency

First Posted Date
2008-04-10
Last Posted Date
2019-10-31
Lead Sponsor
Imperial College London
Target Recruit Count
5
Registration Number
NCT00655707
Locations
πŸ‡¬πŸ‡§

Imperial College Healthcare Trust, London, United Kingdom

Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date
2008-04-10
Last Posted Date
2019-07-10
Lead Sponsor
Imperial College London
Registration Number
NCT00655694
Locations
πŸ‡¬πŸ‡§

National Heart and Lung Institute, London, United Kingdom

Modulation of Lung Injury Complicating Lung Resection

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-04-10
Last Posted Date
2020-02-05
Lead Sponsor
Imperial College London
Target Recruit Count
52
Registration Number
NCT00655928
Locations
πŸ‡¬πŸ‡§

Royal Brompton Hospital, London, United Kingdom

Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum

First Posted Date
2008-04-10
Last Posted Date
2019-07-10
Lead Sponsor
Imperial College London
Target Recruit Count
72
Registration Number
NCT00655954
Locations
πŸ‡¬πŸ‡§

National Heart and Lung Institute, London, United Kingdom

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-04-01
Last Posted Date
2019-08-20
Lead Sponsor
Imperial College London
Target Recruit Count
18
Registration Number
NCT00649961
Locations
πŸ‡¬πŸ‡§

Imperial College Healthcare NHS Trust, London, United Kingdom

πŸ‡¬πŸ‡§

Royal Bolton Hospital, Bolton, United Kingdom

Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis

First Posted Date
2008-03-31
Last Posted Date
2019-12-12
Lead Sponsor
Imperial College London
Target Recruit Count
140
Registration Number
NCT00647348
Locations
πŸ‡¬πŸ‡§

MRI Unit, National Society for Epilepsy, Chesham Lane, Chalfont St. Peter, Buckinghamshire, United Kingdom

πŸ‡¬πŸ‡§

Charing Cross Hospital, Fulham Palace Road, Hammersmith, London, United Kingdom

πŸ‡¬πŸ‡§

Brighton & Sussex University Hospitals NHS Trust, Eastern Road, Brighton, United Kingdom

Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment

First Posted Date
2008-03-10
Last Posted Date
2019-07-08
Lead Sponsor
Imperial College London
Target Recruit Count
88
Registration Number
NCT00632255
Locations
πŸ‡¬πŸ‡§

Haematology Department. Catherine Lewis Centre. Hammersmith Hospital. Du Cane Road., London, United Kingdom

Stem Cells and Tibial Fractures

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2008-03-10
Last Posted Date
2019-07-15
Lead Sponsor
Imperial College London
Registration Number
NCT00632034
Locations
πŸ‡¬πŸ‡§

Charing Cross Hospital, London, United Kingdom

Β© Copyright 2024. All Rights Reserved by MedPath